Canada Gastric Cancer Diagnostics Market to 2032
Overview
The Canada Gastric Cancer Diagnostics Market is expected to reach a 84.50 USD Million by 2032 and is projected to grow at a CAGR of 9.95% from 2025 to 2032.
Revenue, 2024 (USD Million)
49.01
Forecast, 2032 (USD Million)
84.50
CAGR, 2024 - 2032
9.95%
Report Coverage
Canada
Canada Gastric Cancer Diagnostics Market 2018-2032 USD Million
Canada Gastric Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 49.01 USD Million
- Projected Market Size (2032): 84.50 USD Million
- CAGR (2025-2032): 9.95%
Key Findings of Canada Gastric Cancer Diagnostics Market
- The Canada Gastric Cancer Diagnostics Market was valued at 49.01 USD Million in 2024.
- The Canada Gastric Cancer Diagnostics Market is likely to grow at a CAGR of 9.95% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 31.17 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 12.99% during the forecast period from 2024 to 2032.
Canada Gastric Cancer Diagnostics Market Scope
Canada Gastric Cancer Diagnostics Market Segmentation & Scope
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Age Group
- Pediatric
- Adult
- Geriatrics
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Stage
- Stage 0
- Stage II
- Stage III
- Stage I
Product Type
- Services
- Instruments
- Reagents & Consumables
Gender
- Female
- Male
Sample Type
- Urine
- Blood
- Tissue
- Stool
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Canada Gastric Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 49.01 USD Million |
| Market Value in 2032 | 84.50 USD Million |
| CAGR (2025-2032) | 9.95% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Diagnostic Type,Age Group,Disease Type,Stage,Product Type,Gender,Sample Type,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Canada, leading in terms of revenue 49.01 USD Million in 2024
- Key Country: Canada, leading in terms of revenue with value of 49.01 USD Million in 2024.
Segments and Scope
-
Canada Gastric Cancer Diagnostics Market to 2032, By Diagnostic Type
- Confirmatory Test is the largest segment in Canada Gastric Cancer Diagnostics Market to 2032 with a revenue of 28.32 USD Million in the year 2024.
- Confirmatory Test is the Fastest growing segment in Canada Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 10.96 % in forecast period 2025-2032.
-
Canada Gastric Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in Canada Gastric Cancer Diagnostics Market to 2032 with a revenue of 26.29 USD Million in the year 2024.
- Geriatrics is the Fastest growing segment in Canada Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.16 % in forecast period 2025-2032.
-
Canada Gastric Cancer Diagnostics Market to 2032, By Disease Type
- Intestinal or Diffuse Adinocarcinoma is the largest segment in Canada Gastric Cancer Diagnostics Market to 2032 with a revenue of 21.28 USD Million in the year 2024.
- Intestinal or Diffuse Adinocarcinoma is the Fastest growing segment in Canada Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.16 % in forecast period 2025-2032.
-
Canada Gastric Cancer Diagnostics Market to 2032, By Stage
- Stage I is the largest segment in Canada Gastric Cancer Diagnostics Market to 2032 with a revenue of 18.52 USD Million in the year 2024.
- Stage I is the Fastest growing segment in Canada Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.42 % in forecast period 2025-2032.
-
Canada Gastric Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in Canada Gastric Cancer Diagnostics Market to 2032 with a revenue of 27.24 USD Million in the year 2024.
- Reagents & Consumables is the Fastest growing segment in Canada Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.87 % in forecast period 2025-2032.
-
Canada Gastric Cancer Diagnostics Market to 2032, By Gender
- Male is the largest segment in Canada Gastric Cancer Diagnostics Market to 2032 with a revenue of 26.30 USD Million in the year 2024.
- Male is the Fastest growing segment in Canada Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 10.85 % in forecast period 2025-2032.
-
Canada Gastric Cancer Diagnostics Market to 2032, By Sample Type
- Stool is the largest segment in Canada Gastric Cancer Diagnostics Market to 2032 with a revenue of 20.00 USD Million in the year 2024.
- Stool is the Fastest growing segment in Canada Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.93 % in forecast period 2025-2032.
-
Canada Gastric Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Canada Gastric Cancer Diagnostics Market to 2032 with a revenue of 17.06 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Canada Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.99 % in forecast period 2025-2032.
-
Canada Gastric Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Canada Gastric Cancer Diagnostics Market to 2032 with a revenue of 31.17 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Canada Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 10.94 % in forecast period 2025-2032.
Canada Gastric Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| BIOMÉRIEUX | |||
| Abbott | |||
| General Electric | |||
| F. Hoffmann-La Roche Ltd. | |||
Canada Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Canada Gastric Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Canada Gastric Cancer Diagnostics Market is segmented based on Segmentation Diagnostic Type,Age Group,Disease Type,Stage,Product Type,Gender,Sample Type,End User,Distribution Channel.
Canada Gastric Cancer Diagnostics Market was valued at USD 49.01(Revenue in USD Million) in 2020.
Canada Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 9.95% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Canada Gastric Cancer Diagnostics Market, holding a largest market share of 31.17 USD Million in 2024
Canada Gastric Cancer Diagnostics Market Scope
Canada Gastric Cancer Diagnostics Market Segmentation & Scope
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Age Group
- Pediatric
- Adult
- Geriatrics
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Stage
- Stage 0
- Stage II
- Stage III
- Stage I
Product Type
- Services
- Instruments
- Reagents & Consumables
Gender
- Female
- Male
Sample Type
- Urine
- Blood
- Tissue
- Stool
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Canada Gastric Cancer Diagnostics Market is segmented based on Segmentation Diagnostic Type,Age Group,Disease Type,Stage,Product Type,Gender,Sample Type,End User,Distribution Channel.
Canada Gastric Cancer Diagnostics Market was valued at USD 49.01(Revenue in USD Million) in 2020.
Canada Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 9.95% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Gastric Cancer Diagnostics Market for final year is USD 84.50 (USD Million).
Canada Gastric Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Canada Gastric Cancer Diagnostics Market is segmented based on Segmentation Diagnostic Type,Age Group,Disease Type,Stage,Product Type,Gender,Sample Type,End User,Distribution Channel.
Canada Gastric Cancer Diagnostics Market was valued at USD 49.01(Revenue in USD Million) in 2020.
Canada Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 9.95% during the forecast period of 2024 to 2032.
The estimated market value of the Canada Gastric Cancer Diagnostics Market for final year is USD 84.50 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.